truncal acne

Special Focus on Acne and Rosacea
Acne and Rosacea
by NEXT STEPS IN DERM TEAM on
The June issue of the Journal of Drugs in Dermatology focuses on the topics of acne and rosacea, and features additional articles on topics such as atopic dermatitis and psoriasis. Straight from the JDD Editor’s desk, we share this month’s issue highlights: Guest Editor James Q. Del Rosso discusses roadblocks that impede patient ability to obtain medications selected by their dermatologist …
Acne News with Dr. Adam Friedman
acne
by NEXT STEPS IN DERM TEAM on
Straight from the desk of ODAC Medical Director, Dr. Adam Friedman, we share what’s popping in acne (spoiler alert: quite a lot!). According to Dr. Friedman, the innovation drought is over! Watch as he reviews all new topical and oral therapeutics (some of which are completely new active agents) and while at it, shares and debunks important information related to the management of acne vulgaris …
ODAC Scientific Poster Highlights: Acne & Rosacea
acne and rosacea
by NEXT STEPS IN DERM TEAM on
During the 2021 ODAC Dermatology, Aesthetic and Surgical Conference held virtually on January 14th-17th, dermatologists from around the country submitted newly published research findings and novel therapeutics in the areas of acne and rosacea, all presented as part of a virtual scientific poster gallery. We share the highlights of each poster below! Efficacy and Safety of Narrow-spectrum Oral …
Topical Treatment of Acne: Pearls from the Expert
topical treatment of acne
by Matthew Willett, MD, FAAD on
You are at the end of a busy afternoon clinic, with only a single patient standing between you and freedom to go visit a good friend and watch the Stanley Cup playoffs, of course after completing a metric ton of electronic charting. The chart in the door (or more likely on the EMR tablet) says “CHIEF COMPLAINT: ACNE”. Do you smile or groan? Acne vulgaris, or “common” acne, is itself among …
Trifarotene for Acne Vulgaris Therapeutic Cheat Sheet
Trifarotene for acne vulgaris
by Blair Allais, MD on
Acne vulgaris is one of the most common reasons for visiting the dermatologist. Topical retinoids are a mainstay of and considered first-line treatment, but patients often face issues with tolerability, which can impact adherence to therapy. We continue our series, Therapeutic Cheat Sheet, with a closer look at the recently FDA approved trifarotene. [caption id="attachment_10430" align="alignle …